|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.880 USD | -4.57% |
|
+8.05% | +37.23% |
| Market Cap | 649M 564M 525M 482M 910M 61.94B 924M 6.19B 2.43B 30.84B 2.44B 2.38B 103B | P/E 2026 * |
-2.65x | P/E 2027 * | -2.46x |
|---|---|---|---|---|---|
| Enterprise Value | 463M 403M 375M 344M 650M 44.22B 660M 4.42B 1.73B 22.01B 1.74B 1.7B 73.82B | EV / Sales 2026 * |
69,446x | EV / Sales 2027 * | 37.6x |
| Free-Float |
83.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | -4.57% | ||
| 1 week | +8.05% | ||
| 1 month | -10.90% | ||
| 3 months | -12.56% | ||
| 6 months | +2.17% | ||
| Current year | +37.23% |
| 1 week | 1.61 |  | 2 |
| 1 month | 1.61 | | 2.18 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 30/06/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 15/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 27/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 31/10/2017 |
David Chang
BRD | Director/Board Member | 66 | 31/05/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 31/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Free | Chief Executive Officer | 610,720 | 0.1769% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.57% | +8.05% | +74.07% | -60.75% | 649M | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -0.57% | -2.61% | +39.69% | +133.26% | 23.45B | |
| Weighted average by Cap. | +0.22% | -2.93% | +30.91% | +116.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.67K 5.8K 5.4K 4.96K 9.36K 637K 9.5K 63.62K 24.97K 317K 25.05K 24.5K 1.06M | 14.59M 12.69M 11.81M 10.84M 20.47M 1.39B 20.79M 139M 54.63M 694M 54.81M 53.61M 2.33B |
| Net income | -197M -172M -160M -147M -277M -18.84B -281M -1.88B -739M -9.38B -741M -725M -31.45B | -231M -201M -187M -172M -324M -22.06B -329M -2.2B -865M -10.98B -868M -849M -36.82B |
| Net Debt | -186M -161M -150M -138M -260M -17.73B -265M -1.77B -695M -8.82B -697M -682M -29.59B | -101M -87.62M -81.56M -74.88M -141M -9.62B -144M -961M -377M -4.79B -379M -370M -16.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | US$1.880 | -4.57% | 5,521,843 |
| 30/07/26 | US$1.970 | +8.84% | 10,523,182 |
| 29/07/26 | US$1.810 | +9.04% | 12,515,086 |
| 28/07/26 | US$1.660 | -5.14% | 9,960,229 |
| 27/07/26 | US$1.750 | +0.57% | 6,901,348 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
